The university has been awarded a $10 million grant from the National Cancer Institute to study the long-term, longitudinal impact of COVID-19 on first responders, health care workers and the general population. The award will fund the Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID), a new Serological Sciences Center of Excellence. Center co-investigators include FAHRP's Linda Saif and Anastasia Vlasova.
Ohio State to study impact of COVID-19 in first responders with $10 million grant